LC
ALKS icon

Lindbrook Capital’s Alkermes ALKS Stock Holding History

Lindbrook Capital’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$14.9K Buy
451
+38
+9% +$1.24K ﹤0.01% 1486
2024
Q4 		$11.9K Buy
413
+24
+6% +$690 ﹤0.01% 1568
2024
Q3 		$10.9K Buy
389
+53
+16% +$1.41K ﹤0.01% 1632
2024
Q2 		$8.1K Sell
336
-57
-15% -$1.4K ﹤0.01% 1747
2024
Q1 		$10.6K Sell
393
-35
-8% -$994 ﹤0.01% 1539
2023
Q4 		$11.9K Sell
428
-80
-16% -$2.08K ﹤0.01% 1456
2023
Q3 		$14.2K Buy
508
+130
+34% +$3.81K ﹤0.01% 1230
2023
Q2 		$11.8K Buy
378
+86
+29% +$2.6K ﹤0.01% 1365
2023
Q1 		$8.23K Sell
292
-81
-22% -$2.21K ﹤0.01% 1581
2022
Q4 		$9.75K Sell
373
-256
-41% -$6.13K ﹤0.01% 1443
2022
Q3 		$14K Buy
629
+24
+4% +$624 ﹤0.01% 1152
2022
Q2 		$18K Hold
605
– – ﹤0.01% 1002
2022
Q1 		$16K Buy
+605
New +$15K ﹤0.01% 1089

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Lindbrook Capital's ALKS Position: Q1 2025 in Review

Lindbrook Capital increased its Alkermes (ALKS) stake by 9.2% in Q1 2025, buying an estimated $1.24K and bringing the position to 451 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

Lindbrook Capital first reported a position in ALKS in Q1 2022 and has held it in 13 quarters since. The position peaked at $18K in Q2 2022. 371 funds tracked by Wall St. Rank hold ALKS as of Q1 2025.

  • Lindbrook Capital held 451 shares of Alkermes worth $14.9K as of Q1 2025.
  • Lindbrook Capital bought 38 Alkermes shares in Q1 2025, an estimated $1.24K.
  • Alkermes made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1486 holding.
  • Lindbrook Capital first reported a position in Alkermes in Q1 2022 and has held it in 13 quarters since.
  • Lindbrook Capital's Alkermes position peaked at $18K in Q2 2022.
  • 371 funds tracked by Wall St. Rank held Alkermes as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.